non-Hodgkin lymphoma
Kite Pharma climbs on strong data showing in lymphoma trial
March 1, 2017Research and Development kite pharma, non-Hodgkin lymphoma
Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …
Phase II failure sees stock plunge and job cutbacks for Infinity Pharmaceuticals
June 15, 2016Research and Development, Sales and Marketing AbbVie, infinity pharmaceuticals, non-Hodgkin lymphoma, trial failure
Shares at Infinity Pharmaceuticals (NASDAQ: INFI) fell around 70% upon the announcement of new Phase II data for their non-Hodgkin …
Kite Pharma, Roche to co-develop two new treatments for non-hodgkin lymphoma
March 18, 2016Medical Communications, Research and Development Gentech, Roche, kite pharma, non-Hodgkin lymphoma
Kite Pharma (Nasdaq: KITE) said it will collaborate with Swiss drug major Roche (SIX: ROG) to evaluate the safety and efficacy …
Spectrum wins FDA approval for rare cancer drug
July 4, 2014Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma
In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
